Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

473 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hypoxia-Associated Gene Signatures Are Not Prognostic in High-Risk Localized Prostate Cancers Undergoing Androgen Deprivation Therapy With Radiation Therapy.
Reardon MD, Bibby BAS, Thiruthaneeswaran N, Pereira RR, Mistry H, More E, Tsang Y, Vickers AJ, Reeves KJ, Henry A, Denley H, Wylie J, Spratt DE, Hakansson A, Ryu M, Smith TAD, Hoskin PJ, Bristow R, Choudhury A, West CML. Reardon MD, et al. Among authors: wylie j. Int J Radiat Oncol Biol Phys. 2024 Oct 16:S0360-3016(24)03465-5. doi: 10.1016/j.ijrobp.2024.10.002. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 39424079 Free article.
External Beam Radiation Therapy (EBRT) and High-Dose-Rate (HDR) Brachytherapy for Intermediate and High-Risk Prostate Cancer: The Impact of EBRT Volume.
Tharmalingam H, Tsang Y, Choudhury A, Alonzi R, Wylie J, Ahmed I, Henry A, Heath C, Hoskin PJ. Tharmalingam H, et al. Among authors: wylie j. Int J Radiat Oncol Biol Phys. 2020 Mar 1;106(3):525-533. doi: 10.1016/j.ijrobp.2019.09.044. Epub 2019 Oct 11. Int J Radiat Oncol Biol Phys. 2020. PMID: 31610249 Free article.
Ten-Year Outcomes of Moderately Hypofractionated Salvage Postprostatectomy Radiation Therapy and External Validation of a Contemporary Multivariable Nomogram for Biochemical Failure.
Chin S, Fatimilehin A, Walshaw R, Argarwal A, Mistry H, Elliott T, Logue J, Wylie J, Choudhury A. Chin S, et al. Among authors: wylie j. Int J Radiat Oncol Biol Phys. 2020 Jun 1;107(2):288-296. doi: 10.1016/j.ijrobp.2020.01.008. Epub 2020 Jan 25. Int J Radiat Oncol Biol Phys. 2020. PMID: 31987961
Single dose high-dose rate (HDR) brachytherapy (BT) as monotherapy for localised prostate cancer: Early results of a UK national cohort study.
Tharmalingam H, Tsang Y, Ostler P, Wylie J, Bahl A, Lydon A, Ahmed I, Elwell C, Nikapota AR, Hoskin PJ; National UK HDR Prostate Brachytherapy Database. Tharmalingam H, et al. Among authors: wylie j. Radiother Oncol. 2020 Feb;143:95-100. doi: 10.1016/j.radonc.2019.12.017. Epub 2020 Feb 7. Radiother Oncol. 2020. PMID: 32044166
Technical development and validation of a clinically applicable microenvironment classifier as a biomarker of tumour hypoxia for soft tissue sarcoma.
Forker LJ, Bibby B, Yang L, Lane B, Irlam J, Mistry H, Khan M, Valentine H, Wylie J, Shenjere P, Leahy M, Gaunt P, Billingham L, Seddon BM, Grimer R, Robinson M, Choudhury A, West C. Forker LJ, et al. Among authors: wylie j. Br J Cancer. 2023 Jun;128(12):2307-2317. doi: 10.1038/s41416-023-02265-3. Epub 2023 Apr 21. Br J Cancer. 2023. PMID: 37085598 Free PMC article.
A combined single high-dose rate brachytherapy boost with hypofractionated external beam radiotherapy results in a high rate of biochemical disease free survival in localised intermediate and high risk prostate cancer patients.
Joseph N, Taylor C, O'Hara C, Choudhury A, Elliott T, Logue J, Wylie J. Joseph N, et al. Among authors: wylie j. Radiother Oncol. 2016 Nov;121(2):299-303. doi: 10.1016/j.radonc.2016.09.016. Epub 2016 Oct 28. Radiother Oncol. 2016. PMID: 28029404 Clinical Trial.
Tolerability of Concurrent Chemoradiation Therapy With Gemcitabine (GemX), With and Without Prior Neoadjuvant Chemotherapy, in Muscle Invasive Bladder Cancer.
Thompson C, Joseph N, Sanderson B, Logue J, Wylie J, Elliott T, Lyons J, Anandadas C, Choudhury A. Thompson C, et al. Among authors: wylie j. Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):732-739. doi: 10.1016/j.ijrobp.2016.11.040. Epub 2016 Nov 27. Int J Radiat Oncol Biol Phys. 2017. PMID: 28244408 Clinical Trial.
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Parker CC, Kynaston H, Cook AD, Clarke NW, Catton CN, Cross WR, Petersen PM, Persad RA, Pugh CA, Saad F, Logue J, Payne H, Bower LC, Brawley C, Rauchenberger M, Barkati M, Bottomley DM, Brasso K, Chung HT, Chung PWM, Conroy R, Falconer A, Ford V, Goh CL, Heath CM, James ND, Kim-Sing C, Kodavatiganti R, Malone SC, Morris SL, Nabid A, Ong AD, Raman R, Rodda S, Wells P, Worlding J, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 Jun 1;403(10442):2416-2425. doi: 10.1016/S0140-6736(24)00549-X. Epub 2024 May 16. Lancet. 2024. PMID: 38763153 Free PMC article. Clinical Trial.
473 results